Ministry of Ayush is conducting the world's first multicenter Phase - III clinical trial examining the efficacy of Ayurveda in the treatment of Rheumatoid Arthritis. The clinical trial will be conducted in accordance with stringent International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use – Good Clinical Practice (ICH- GCP) guidelines.

This project is one of the first multi-center phase III double blind double dummy clinical trials on the efficacy of Ayurveda in the management of Rheumatoid Arthritis. This will be conducted by AVP Research Foundation, a research institution affiliated with The Arya Vaidya Pharmacy (Coimbatore) Ltd and the Central Council of Research in Ayurvedic Sciences under Ministry of Ayush, Govt of India.

Dr. Daniel Furst, a renowned rheumatologist at University of California Los Angeles in the United States of America has designed the study and will be mentoring it. In connection with this trial Dr. Daniel, has started training all the investigators from centers on the conduct of the study adhering to the gold standards of clinical research, thus enabling globalization of Ayurveda.

Dr. Somit Kumar, Director, AVP Research Foundation and Co-Investigator of this study said, “AMRA, a double blind double dummy randomised clinical trial, is taking Ayurveda research in Rheumatology to a global stage.”

Dr. M. N. Shubhashree, Research Officer & Principal Investigator from the nodal center, Central Ayurveda Research Institute, Bengaluru, “The study is expected to begin in May 2022 and will be completed in two years. The sample size has been significantly increased to 240. Clinical trials will be conducted at three locations; AVP Research Foundation in Coimbatore, Central Ayurveda Research Institute in Bengaluru and the Raja Ramdeo Anandilal Podar Central Ayurveda Research Institute in Mumbai.”

Earlier, the National Institutes of Health in the United States of America funded a clinical trial at the University of Washington in Seattle to compare the efficacy and safety of classical Ayurvedic treatment to standard Allopathic treatment for rheumatoid arthritis. The findings of this study have been published in prestigious journals such as the Annals of Rheumatic Diseases and the Journal of Clinical Rheumatology.

****

SK

 

(Release ID: 1809672)